BMRB Entry 50813

Title:
Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity
Deposition date:
2021-03-09
Original release date:
2021-05-05
Authors:
Park, Sang Ho; Siddiqi, Haley; Castro, Daniela; Opella, Stanley
Citation:

Citation: Park, Sang Ho; Siddiqi, Haley; Castro, Daniela; De Angelis, Anna; Oom, Aaron; Stoneham, Charlotte; Lewinski, Mary; Clark, Alex; Croker, Ben; Carlin, Aaron; Guatelli, John; Opella, Stanley. "Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity."  PLoS Pathog. 17, e1009519-e1009519 (2021).
PubMed: 34003853

Assembly members:

Assembly members:
entity_1, polymer, 75 residues, Formula weight is not available

Natural source:

Natural source:   Common Name: SARS-CoV-2   Taxonomy ID: 2697049   Superkingdom: Viruses   Kingdom: not available   Genus/species: Betacoronavirus HCoV-SARS

Experimental source:

Experimental source:   Production method: recombinant technology   Host organism: Escherichia coli   Vector: pET-31b(+)

Entity Sequences (FASTA):

Data sets:
Data typeCount
13C chemical shifts144
15N chemical shifts72
1H chemical shifts72

Additional metadata:

  • Assembly
  • Samples and Experiments
  • Software
  • Spectrometers
  • Hide all

Assembly:

Entity Assembly IDEntity NameEntity ID
1SARS-CoV-2 envelope protein1

Entities:

Entity 1, SARS-CoV-2 envelope protein 75 residues - Formula weight is not available

1   METTYRSERPHEVALSERGLUGLUTHRGLY
2   THRLEUILEVALASNSERVALLEULEUPHE
3   LEUALAPHEVALVALPHELEULEUVALTHR
4   LEUALAILELEUTHRALALEUARGLEUCYS
5   ALATYRCYSCYSASNILEVALASNVALSER
6   LEUVALLYSPROTHRVALTYRVALTYRSER
7   ARGVALLYSASNLEUASNSERSERARGVAL
8   PROASPLEULEUVAL

Download HSQC peak lists in one of the following formats:
CSV: Backbone or all simulated peaks
SPARKY: Backbone or all simulated peaks